Watch Ticker

SELLAS Life Sciences Group, Inc. Common Stock

Go to SELLAS Life Sciences Group, Inc. Common Stock Website

$1.59

-0.07 (-4.22%)

Live

Previous Close

$1.66

Day Range

$1.58 - $1.675

Previous Day Range

$1.562 - $1.71

Market Cap

$165.6 million USD

Day Vol.

1.5 million

Previous Day Vol.

1.8 million

Currency

USD

Primary Exchange

Nasdaq

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a p...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

Several biotech companies are advancing cancer research with promising clinical milestones, focusing on innovative immunotherapies and targeted treatments amid rising cancer incidence and potential research funding challenges.

Related tickers: ONCY, ZLAB, GOVX, GOVXW, OSTX, SLS.

Read Full Article

Sellas Life Sciences Group, Inc. - SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting

SELLAS presented preclinical data showing that its CDK9 inhibitor SLS009 demonstrated potent anti-proliferative activity in ASXL1 mutant colorectal cancer cell lines, suggesting its potential as a targeted therapy for this patient population.

Related tickers: SLS.

Read Full Article

Trending Tickers

Please sign in to view